QuidelOrtho Corporation’s Market Journey: Closing Weak at 28.09, Down -8.08

Ulysses Smith

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

The closing price of QuidelOrtho Corporation (NASDAQ: QDEL) was $28.09 for the day, down -8.08% from the previous closing price of $30.56. In other words, the price has decreased by -$8.08 from its previous closing price. On the day, 1.26 million shares were traded. QDEL stock price reached its highest trading level at $30.245 during the session, while it also had its lowest trading level at $27.985.

Ratios:

Our analysis of QDEL’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.98 and its Current Ratio is at 1.78. In the meantime, Its Debt-to-Equity ratio is 1.40 whereas as Long-Term Debt/Eq ratio is at 1.30.

On May 08, 2025, Jefferies Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $44.

Citigroup Upgraded its Neutral to Buy on December 11, 2024, whereas the target price for the stock was revised from $44 to $50.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 10 ’25 when RHOADS ANN D bought 750 shares for $28.27 per share. The transaction valued at 21,206 led to the insider holds 15,021 shares of the business.

Wilkins Joseph D Jr. bought 370 shares of QDEL for $10,343 on Nov 26 ’25. The Director now owns 11,876 shares after completing the transaction at $27.95 per share. On Nov 25 ’25, another insider, WIDDER KENNETH J, who serves as the Director of the company, sold 4,026 shares for $27.81 each. As a result, the insider received 111,965 and left with 37,061 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, QDEL now has a Market Capitalization of 1908196864 and an Enterprise Value of 4674296832. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.57. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.70 while its Price-to-Book (P/B) ratio in mrq is 0.94. Its current Enterprise Value per Revenue stands at 1.722 whereas that against EBITDA is 8.091.

Stock Price History:

The Beta on a monthly basis for QDEL is 0.68, which has changed by -0.37743795 over the last 52 weeks, in comparison to a change of 0.15024745 over the same period for the S&P500. Over the past 52 weeks, QDEL has reached a high of $46.24, while it has fallen to a 52-week low of $19.50. The 50-Day Moving Average of the stock is -0.76%, while the 200-Day Moving Average is calculated to be -0.42%.

Shares Statistics:

QDEL traded an average of 1.25M shares per day over the past three months and 1193190 shares per day over the past ten days. A total of 67.90M shares are outstanding, with a floating share count of 67.24M. Insiders hold about 1.02% of the company’s shares, while institutions hold 121.39% stake in the company. Shares short for QDEL as of 1767139200 were 11249168 with a Short Ratio of 9.03, compared to 1764288000 on 11475641. Therefore, it implies a Short% of Shares Outstanding of 11249168 and a Short% of Float of 27.500000000000004.

Earnings Estimates

. The current rating of QuidelOrtho Corporation (QDEL) reflects the combined expertise of 6.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is $0.81, with high estimates of $0.97 and low estimates of $0.7.

Analysts are recommending an EPS of between $2.11 and $2.06 for the fiscal current year, implying an average EPS of $2.08. EPS for the following year is $2.51, with 6.0 analysts recommending between $2.76 and $2.25.

Revenue Estimates

It is expected that $90B in revenue will be generated in. The current quarter, according to 7 analysts. It ranges from a high estimate of $707.08M to a low estimate of $697.05M. The current estimate, QuidelOrtho Corporation’s year-ago sales were $707.8MFor the next quarter, 7 analysts are estimating revenue of $712.38M. There is a high estimate of $735.64M for the next quarter, whereas the lowest estimate is $703.3M.

A total of 7 analysts have provided revenue estimates for QDEL’s current fiscal year. The highest revenue estimate was $2.71B, while the lowest revenue estimate was $2.7B, resulting in an average revenue estimate of $2.71B. In the same quarter a year ago, actual revenue was $2.78BBased on 7 analysts’ estimates, the company’s revenue will be $2.77B in the next fiscal year. The high estimate is $2.78B and the low estimate is $2.75B.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.